← Eichor
Study identifier: NCT03048201 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Physica System Total Knee Replacement Registry Study

Condition: Osteoarthritis, Knee · Traumatic Arthritis · Avascular Necrosis  ·  Sponsor: Limacorporate S.p.a

PhaseNA
Planned participants800
Who can joinAll sexes, 22 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective of this study is to obtain long-term implant survivorship (out to 10 years) and to assess clinical, patient-reported outcome measures, and radiographic data for the commercially available Physica system. For ancillary arm, from baseline to 5-year follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Fabiana Pavan  ·  +390432945357  ·  Fabiana.Pavan@limacorporate.com

Federica Azzimonti  ·  federica.azzimonti@limacorporate.com

Always discuss trial participation with your own doctor first.

Locations (5)

Eisenhower Desert Orthopedics Center - Harry and Diane Rinker BldgRancho Mirage, California, United StatesRecruiting
The Orthopedics ClinicDaytona Beach, Florida, United StatesRecruiting
Rush Castle OrthopaedicsAurora, Illinois, United StatesRecruiting
Syracuse Orthopedic SpecialistsSyracuse, New York, United StatesCompleted
Joint Reconstructive SpecialistOklahoma City, Oklahoma, United StatesCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03048201